PRE Prenetics Global Ltd

P/E --
Forward P/E --
Price/Sales 2.523
Beta 0.254
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Prenetics Global is trading 6% up in pre-market

Prenetics Global is trading at $21.47, up 5.98%, in pre-market; the reason for the October 16 gain remains unclear. - No verified company-specific...

🟒 Prenetics Global is trading 7% up in after-hours trading with no verified company-specific announcement identified

Prenetics Global is trading 7.11% higher at $21.70 after-hours; no verified company-specific announcement from October 15 surfaced in available search...

πŸ”΄ Prenetics Global is trading 8.3% down in pre-market amid rising oil prices and Treasury yields

Prenetics Global is trading at $20.60, down 8.3%, as broader market weakness may be contributing; no direct company-specific trigger was identified. - Shares...

🟒 Prenetics Global is trading 10.3% up; no clear catalyst identified

Prenetics Global is trading at $22.50, up 10.32% on October 7, 2026, with no clear company-specific catalyst identified. - Its investor-relations page showed...

🟒 Prenetics Global is trading 7% up with no clear company-specific catalyst

Prenetics Global is trading at $21.80, up 6.86%, with no clear company-specific announcement identified to explain the October 7 rise. - Its...

πŸ”΄ Prenetics Global is trading 5% down with no direct cause confirmed

Prenetics Global is trading 5.20% lower at $19.87 on October 6, 2026, with no direct cause confirmed. - Biotech shares were also under pressure: XBI was...

🟒 Prenetics Global is trading 5.6% up in pre-market

Prenetics Global is trading at $21.29, up +5.55%, in pre-market, with no confirmed catalyst identified. - No clear company-specific announcement explaining...

πŸ”΄ Prenetics Global is trading 5% down; catalyst remains unclear

Prenetics Global is trading 5.01% down at $20.85, with no clear company-specific catalyst identified for October 2, 2026. - The company’s investor-relations...

πŸ”΄ Prenetics Global is trading 5% down as the cause remains unclear

Prenetics Global is trading 5.06% lower now at $21.96 on October 1, 2026; the cause of the decline remains unclear. - The sharp move contrasts with the prior...

🟒 Prenetics Global is trading 11.07% up in pre-market amid positive biotech-sector sentiment

Prenetics Global is trading at $25.22, up 11.07%, with the move appearing linked mainly to positive biotechnology-sector sentiment. - XBI was up 2.61%...

πŸ”΄ Prenetics Global is trading 5.55% down today with no clear company-specific explanation

Prenetics Global is trading 5.55% down at $22.99 on September 22, 2026, apparently driven by trading-specific positioning or an undisclosed catalyst rather...

🟒 Prenetics Global is trading 11% up today as biotech shares rally

Prenetics Global is trading 10.94% up at $24.43 as biotechnology shares rally alongside stronger U.S. equities and improved risk appetite. - The move appears...

🟒 Prenetics Global is trading 5.45% up today amid stronger U.S. equities and a biotechnology-sector rally

Prenetics Global is trading 5.45% up at $23.24, supported by stronger U.S. equities, improving risk appetite and a biotechnology-sector rally. - Premarket...

🟒 Prenetics Global is trading 5.9% up in pre-market amid stronger U.S. futures and risk-on sentiment

Prenetics Global is trading at $23.32, up +5.90%, on September 17, 2026, with the move appearing aligned with stronger U.S. futures and broad risk-on...

πŸ”΄ Prenetics Global is trading 5.6% down today as biotech ETF falls 2.11%

Prenetics Global is trading 5.6% down at $21.79 as continued weakness across biotech and growth stocks weighs on sentiment. - The biotech sector ETF is down...

πŸ”΄ Prenetics Global is trading 5.3% down today amid escalating U.S.-Iran tensions

Prenetics Global is trading at $24.26, down 5.3%, as U.S. equities weaken amid escalating U.S.-Iran tensions and Brent crude exceeds $100 per barrel. - S&P...

Prenetics Rated Buy With $37 Target, Citing Beckham-Backed IM8 Brand

B. Riley Financial initiated coverage on Prenetics Global Ltd with a Buy rating. The firm set a $37.00 price target, suggesting a potential upside of over...